Skip to main content
. Author manuscript; available in PMC: 2009 Dec 14.
Published in final edited form as: Neuroendocrinology. 2007 Oct 9;87(2):121–128. doi: 10.1159/000109664

Table 3.

Fold changes in mRNA abundance relative to control fetus. There were no statistically significant differences between groups for any of the measured genes. Data are reported as mean values±SEM.

gene tissue control fetus ICI treated fetus

(fold change from mean control value)
CRH Hypothalamus 1.16 ± 0.32 1.91 ± 0.91
AVP Hypothalamus 1.27 ± 0.37 1.78 ± 0.99
PC1 Pituitary 1.04 ± 0.13 1.18 ± 0.11
POMC Pituitary 1.14 ± 0.11 1.17 ± 0.30
oLH Pituitary 1.24 ± 0.21 1.46 ± 0.47
oFSH Pituitary 1.07 ± 0.17 2.43 ± 0.54
oPRL Pituitary 1.43 ± 0.51 1.31 ± 0.27
sgk-1 Pituitary 1.03 ± 0.12 1.09 ± 0.27
sgk-1 Hippocampus 1.01 ± 0.06 1.33 ± 0.16